Armenia’s commercial banks purchase about $120.9 mln at intra-banking forex market last week

YEREVAN, December 22. /ARKA/. Armenian commercial banks purchased about $120.9 mln at a weighted average rate of 488.17rams per $1 in intra-banking foreign exchange market on December 15 to December 20, the press service of the Central Bank reported.

In the same period, 9.6 mln euros and about 722.7 mln rubles were purchased on the intra-banking forex market at weighted average exchange rates of 599.65 drams per €1 and 7.84 drams per ruble respectively.

At the same time, about $150.8mln, €12.8mln and about 367.2mln rubles were sold on the intra-banking forex market at weighted average exchange rates of 495 drams, 621.57drams and 8.25drams respectively.

Dram loans extended by Armenian banks during the week before (December 8-14) totaled about 50.8bln drams; dollar loans amounted to a total of $73.1mln. ($1=455.75drams). –0–

spot_img

POPULAR

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

“AGROVISION” CJSC’s bonds were listed on Armenia Stock Exchange

YEREVAN, August 17. /ARKA/.  Today, “AGROVISION” CJSC, a company operating in the agro-industrial sector, became a listed company on the Armenia Stock Exchange (AMX).

An unusual $2.2 million banking scam uncovered in Armenia

YEREVAN, August 14. /ARКА/. A man suspected of embezzling 802.5 million drams from a bank and money laundering has been arrested in Armenia. The preliminary investigation has been completed, the press service of the RA Investigative Committee reported.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img